Руководство по приготовлению препаратов с феруловой кислотой: растворимость, витамины C и E, а также стабильность

Руководство по составлению рецептур · ZLEY Group
Source check: 30 October 2026. This guide separates published supplier specifications from proposed development checks. It does not report a new ZLEY clinical study or establish a finished-product claim.

Formulating a ferulic acid serum starts with a practical question: will the selected grade remain dissolved and chemically stable in the complete product throughout storage and use? A clear beaker immediately after mixing is only the beginning. Solvent balance, dilution, temperature, pH, antioxidant partners and packaging all need to work together. This guide helps professional formulators evaluate ZLEY®FA ferulic acid, design informative bench trials and prepare a useful technical request.

Ferulic acid identity and published ZLEY FA specifications

Ferulic acid is used in antioxidant and brightening skincare development. Its identity should be kept separate from that of ferulate salts, esters and multi-ingredient delivery systems. These materials may require different solvents, addition routes and active-content calculations. A product name that includes “ferulic” does not establish that two commercial grades are interchangeable.

The difference between the SDS solubility statement and the TDS incorporation wording matters. Incorporation into a water-containing formulation is not the same as dissolving a powder directly in water. Before scaling a process, ask the supplier to specify solvent identity, concentration, mixing order, temperature and the conditions under which the solution stays clear. Do not convert an ambiguous document phrase into a universal water-solubility claim.

How to screen a ferulic acid solvent system

Define the desired product architecture first: an aqueous serum, hydroalcoholic system, emulsion or anhydrous oil product. The acceptable solvent package depends on that architecture, sensory targets, customer requirements and the other ingredients. A solvent that dissolves ferulic acid in isolation may lose capacity when the concentrate is diluted into a high-water base. The final solvent fraction therefore matters as much as the pre-mix concentration.

Prepare a small screening matrix rather than changing several variables without recording them. Keep raw-material grade and batch fixed. Compare candidate solvent packages at the intended active level, with a base-only control and a deliberately conservative starting process. Record the actual addition sequence and mixing conditions. If heat is necessary, document the temperature and residence time and check whether precipitation occurs after returning to storage temperature.

1. Check identity, lot number and current supplier handling instructions before weighing.
2. Prepare the candidate concentrate and record its appearance after a defined mixing period.
3. Add it to the full formula, including electrolytes, polymers, fragrance and the intended preservative system.
4. Inspect immediately, after equilibration and after cooling; use microscopy when crystals may be difficult to see.
5. Repeat the observation under the proposed storage conditions and after a realistic dilution or process variation.

Consider the full manufacturing window. A laboratory operator may add a concentrate slowly into a well-mixed beaker, while a larger vessel experiences local concentration gradients. Those gradients can generate crystals or an unstable intermediate. Record order of addition, hold time and mixing efficiency so that a successful trial describes a reproducible process instead of a single fortunate observation.

Choosing pH without inventing a universal range

The linked ZLEY FA powder TDS does not define a universal finished-formula pH range. Establish the target using the intended product, solvent system, other actives and preservation design. Measure pH after equilibration using a suitable method, then track it during stability work. In an anhydrous product, a conventional aqueous pH reading is not directly applicable; agree on any extraction or dilution method before comparing results.

Adjusting pH may affect clarity, but clarity is not a substitute for chemical analysis. Changes can also alter viscosity, skin feel, preservative performance and the behavior of other ingredients. Treat pH as a controlled development variable and evaluate the complete outcome. Avoid borrowing a pH specification from a different commercial ferulic blend or assuming that a clear neutralized sample validates the original powder process.

Ferulic acid with vitamins C and E: using the evidence correctly

Lin and colleagues, Journal of Investigative Dermatology, 2005, investigated a defined topical combination of ferulic acid, L-ascorbic acid and alpha-tocopherol. The study reported improved vitamin stability and protection against experimental irradiation in its tested system. It provides a rationale for evaluating combinations, rather than proof that every serum containing these ingredient names will perform the same way.

Changing the vitamin C derivative, solvent package, concentrations or packaging creates a different formulation. Likewise, an ingredient study does not establish the performance of a specific ZLEY grade without an appropriate connection between the tested material and supplied specification. Keep the paper, supplier documentation and your own product data as separate evidence layers when developing a technical presentation.

For a combination screen, compare the base, individual active systems and the combination under matched storage and analytical conditions. This makes it easier to identify whether a change comes from the solvent package, an antioxidant partner or the full mixture. A combination that performs well in an assay still needs physical stability, preservative efficacy, compatibility and tolerance assessment appropriate to the marketed product.

Antioxidant positioning also needs careful claim boundaries. Ferulic acid is not a reason to assign an SPF value to an untested product. A sun-care formula needs its own applicable efficacy and regulatory work. A literature observation about experimental photoprotection cannot be transferred directly to a label claim, a sunscreen replacement message or a numerical claim about a new commercial serum.

A useful stability and packaging plan

Agree on acceptance criteria before interpreting a trial. These should cover the active assay, appearance, odor, pH where meaningful, viscosity, precipitation and packaging behavior. The criteria and storage schedule should reflect the product and proposed shelf life. Accelerated observations help identify vulnerabilities; they do not automatically establish a commercial expiry date without a justified program and supporting real-time data.

Packaging trials should reflect repeated opening or dispensing, transport and storage. Compare light exposure and oxygen access where relevant. An airless or opaque pack is a development option, not a guarantee of stability. Evaluate the actual components and dispensing system, including whether product remains around the outlet and changes color during consumer use.

Troubleshooting crystals, color changes and viscosity drift

If crystals appear after cooling, revisit final solvent capacity and the process route before adding more ingredients. Confirm whether the sediment contains the active or another formula component. If color changes, examine active content and packaging comparisons rather than attributing every change to oxidation without data. When viscosity drifts, inspect pH, polymer compatibility, electrolytes and mixing history alongside the antioxidant system.

Retain a reference sample and trace each change to a recorded formulation version. If two variables change together, repeat a smaller comparison that separates their effects. Procurement substitutions also belong in this record: a different solvent grade, fragrance or polymer can alter the environment even when the ferulic acid purchase specification remains unchanged.

During handover to manufacturing, keep the approved solvent package, material grade and mixing sequence in the master procedure. Define what operators should do if the concentrate is cloudy or the batch deviates from its expected appearance. A clear escalation point is preferable to undocumented extra heating, solvent additions or pH adjustments that may change both performance and the approved composition.

Qualifying a ferulic acid supplier for B2B production

Ask for a current TDS, SDS, lot-specific COA, assay method, impurity specification, packaging details and change-control information. Confirm whether the material used in your trial represents routine commercial supply. Availability, MOQ, destination documentation and lead time should be confirmed in the quotation rather than inferred from a product listing. Request certification scope and validity where relevant to your qualification process.

A productive sample request explains the intended format, active level, target pH if applicable, solvent constraints, processing limits and destination market. Include the observed problem when troubleshooting: for example, delayed precipitation after cooling or color drift in a particular package. This context lets the supplier respond with a relevant process clarification and document set instead of a generic brochure.

Request ZLEY FA samples / current TDS, SDS and COA

Sources and scope

• ZLEY FA published TDS: identity, purity, suggested use level, incorporation wording and storage.
• ZLEY FA published SDS: handling and water-solubility statement.
• Lin et al., 2005, PMID 16185284: defined antioxidant-combination study; not a ZLEY finished-product trial.